OpenAI recently confirmed that it has invested in its co-founder Sam Altman's Merge Labs, a brain computer interface startup.

LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

OpenAI has invested in Merge Labs, a brain-computer interface (BCI) startup co-founded by OpenAI CEO Sam Altman. The startup ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

The MarketWatch News Department was not involved in the creation of this content. Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

OpenAI-backed Merge Labs is working to safely interface biology, hardware devices, and AI at higher bandwidth.

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

Lewes, Delaware, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Global Brain Computer Interface (BCI) Market Size is projected to grow at a CAGR of 14.61 % from 2026 to 2032, according to a new report ...